|
IL17RA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.985900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.623100E-03 |
| Normal-vs-Stage2 |
1.286390E-02 |
| Normal-vs-Stage3 |
1.797490E-04 |
| Normal-vs-Stage4 |
8.769500E-04 |
| Stage1-vs-Stage2 |
7.366400E-01 |
| Stage1-vs-Stage3 |
2.044400E-01 |
| Stage1-vs-Stage4 |
3.042800E-01 |
| Stage2-vs-Stage3 |
5.990000E-01 |
| Stage2-vs-Stage4 |
6.178600E-01 |
| Stage3-vs-Stage4 |
9.459800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.401400E-03 |
| Normal-vs-AfricanAmerican |
3.576400E-03 |
| Normal-vs-Asian |
9.515300E-03 |
| Caucasian-vs-AfricanAmerican |
4.506400E-01 |
| Caucasian-vs-Asian |
9.620000E-01 |
| AfricanAmerican-vs-Asian |
4.932200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.590500E-04 |
| Normal-vs-Female |
8.238500E-04 |
| Male-vs-Female |
4.147600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.540300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.137020E-03 |
| Normal-vs-Age(61-80Yrs) |
5.85290000000294E-05 |
| Normal-vs-Age(81-100Yrs) |
8.826200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.202600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.481900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.972850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.350000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.498040E-01 |
| Classical-VS-Follicular |
1.205050E-04 |
| Classical-VS-Other |
6.156300E-02 |
| Classical-VS-Normal |
1.221510E-02 |
| Tall-VS-Follicular |
2.508800E-01 |
| Tall-VS-Other |
2.218200E-01 |
| Tall-VS-Normal |
1.776430E-03 |
| Follicular-VS-Other |
6.124000E-01 |
| Follicular-VS-Normal |
2.59769999999548E-06 |
| Other-VS-Normal |
4.879200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.155090E-03 |
| Normal-vs-N1 |
3.93859999999746E-05 |
| N0-vs-N1 |
1.646020E-01 |
|
|
